Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1998 1
1999 4
2000 7
2001 3
2002 6
2004 2
2005 3
2008 4
2009 2
2010 2
2011 4
2013 1
2014 1
2016 2
2017 1
2018 3
2019 1
2020 1
2021 1
2022 2
2023 6
2024 5
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.
Minowa T, Murata K, Mizue Y, Murai A, Nakatsugawa M, Sasaki K, Tokita S, Kubo T, Kanaseki T, Tsukahara T, Handa T, Sato S, Horimoto K, Kato J, Hida T, Hirohashi Y, Uhara H, Torigoe T. Minowa T, et al. Among authors: mizue y. Sci Transl Med. 2024 Dec 4;16(776):eadk8832. doi: 10.1126/scitranslmed.adk8832. Epub 2024 Dec 4. Sci Transl Med. 2024. PMID: 39630887
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.
Hori K, Yamada S, Murata K, Miyata H, Mizue Y, Murai A, Minowa T, Sasaki K, Shijubou N, Kubo T, Morita R, Tokita S, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Hori K, et al. Among authors: mizue y. Hum Vaccin Immunother. 2024 Dec 31;20(1):2414542. doi: 10.1080/21645515.2024.2414542. Epub 2024 Nov 13. Hum Vaccin Immunother. 2024. PMID: 39539024 Free PMC article.
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.
Yamada S, Miyata H, Isono M, Hori K, Yanagawa J, Murai A, Minowa T, Mizue Y, Sasaki K, Murata K, Tokita S, Nakatsugawa M, Iwabuchi S, Hashimoto S, Kubo T, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Yamada S, et al. Among authors: mizue y. Cancer Immunol Immunother. 2023 Jul;72(7):2057-2065. doi: 10.1007/s00262-023-03388-5. Epub 2023 Feb 16. Cancer Immunol Immunother. 2023. PMID: 36795123 Free PMC article.
High aldehyde dehydrogenase 1 activity is related to radiation resistance due to activation of AKT signaling after insulin stimulation in prostate cancer.
Wakamiya T, Hirohashi Y, Murai A, Yanagawa J, Mizue Y, Kubo T, Hashimoto S, Murata K, Kanaseki T, Tsukahara T, Nishida S, Kohjimoto Y, Hara I, Torigoe T. Wakamiya T, et al. Among authors: mizue y. Biochem Biophys Res Commun. 2022 Jan 29;590:117-124. doi: 10.1016/j.bbrc.2021.12.095. Epub 2021 Dec 28. Biochem Biophys Res Commun. 2022. PMID: 34974299
65 results